Related Articles for PubMed (Select 18495016)

High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients.

Lips IM, Dehnad H, van Gils CH, Boeken Kruger AE, van der Heide UA, van Vulpen M.

Radiat Oncol. 2008 May 21;3:15.

PMID: 18495016 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes.

Cahlon O, Zelefsky MJ, Shippy A, Chan H, Fuks Z, Yamada Y, Hunt M, Greenstein S, Amols H.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):330-7. Epub 2007 Dec 31.

PMID: 18164858 [PubMed - indexed for MEDLINE]

A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.

Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D'Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):338-45. Epub 2008 Jan 22.

PMID: 18207665 [PubMed - indexed for MEDLINE]

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34.

PMID: 15752881 [PubMed - indexed for MEDLINE]

Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9.

PMID: 18313526 [PubMed - indexed for MEDLINE]

A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.

Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, Chen P, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):400-8.

PMID: 15667959 [PubMed - indexed for MEDLINE]

Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.

Cheng JC, Schultheiss TE, Nguyen KH, Wong JY.

Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):351-7. Epub 2007 Dec 31.

PMID: 18164841 [PubMed - indexed for MEDLINE]

Diabetes mellitus: a predictor for late radiation morbidity.

Herold DM, Hanlon AL, Hanks GE.

Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):475-9.

PMID: 10078625 [PubMed - indexed for MEDLINE]

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.

Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71.

PMID: 16168838 [PubMed - indexed for MEDLINE]

10:

Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients.

De Meerleer G, Vakaet L, Meersschout S, Villeirs G, Verbaeys A, Oosterlinck W, De Neve W.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):777-87. Review.

PMID: 15465194 [PubMed - indexed for MEDLINE]

11:

Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis.

Teh BS, Mai WY, Uhl BM, Augspurger ME, Grant WH 3rd, Lu HH, Woo SY, Carpenter LS, Chiu JK, Butler EB.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):705-12.

PMID: 11172952 [PubMed - indexed for MEDLINE]

12:

Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.

Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G.

Radiother Oncol. 2007 Aug;84(2):148-55. Epub 2007 Aug 9.

PMID: 17692416 [PubMed - indexed for MEDLINE]

13:

Influence of intensity-modulated radiotherapy on acute genitourinary and gastrointestinal toxicity in the treatment of localized prostate cancer.

Jani AB, Gratzle J, Correa D.

Technol Cancer Res Treat. 2007 Feb;6(1):11-5.

PMID: 17241095 [PubMed - indexed for MEDLINE]

14:

Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.

Kitamura K, Shirato H, Shinohara N, Harabayashi T, Onimaru R, Fujita K, Shimizu S, Nonomura K, Koyanagi T, Miyasaka K.

Cancer J. 2003 Jul-Aug;9(4):268-76.

PMID: 12967137 [PubMed - indexed for MEDLINE]

15:

Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.

Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.

Brachytherapy. 2008 Jan-Mar;7(1):1-6.

PMID: 18299108 [PubMed - indexed for MEDLINE]

16:

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

Shu HK, Lee TT, Vigneauly E, Xia P, Pickett B, Phillips TL, Roach M.

Urology. 2001 Jan;57(1):102-7.

PMID: 11164152 [PubMed - indexed for MEDLINE]

17:

Anatomy-based inverse planning dose optimization in HDR prostate implant: a toxicity study.

Mahmoudieh A, Tremblay C, Beaulieu L, Lachance B, Harel F, Lessard E, Pouliot J, Vigneault E.

Radiother Oncol. 2005 Jun;75(3):318-24.

PMID: 16086913 [PubMed - indexed for MEDLINE]

18:

Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields.

Jani AB, Su A, Correa D, Gratzle J.

Prostate Cancer Prostatic Dis. 2007;10(1):82-6. Epub 2006 Sep 19.

PMID: 16983394 [PubMed - indexed for MEDLINE]

19:

Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate.

Schultheiss TE, Hanks GE, Hunt MA, Lee WR.

Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):643-9.

PMID: 7790250 [PubMed - indexed for MEDLINE]

20:

[Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer]

Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.

Cancer Radiother. 2004 Apr;8(2):59-69. English, French.

PMID: 15063872 [PubMed - indexed for MEDLINE]

Recent Activity